Hansa Biopharma AB (publ)

SSE:HNSA.ST

32.64 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income -831.72-611.134-548.282-422.807-359.668-246.498-176.083-111.135-66.201-24.709-17.639-16.80800-15.741-15.906
Depreciation & Amortization 10.73812.0548.6067.6667.4631.8373.7793.4450.9891.3490.0970.127000.3820.415
Deferred Income Tax -60.636-58.226-56.6240000000000000
Stock Based Compensation 60.63658.22656.62443.3487.24616.0750.190.3430.1990000000
Change In Working Capital 11.43621.4322.88781.27610.7428.70412.78912.3817.095-0.1012.71-4.301-2.697-0.1981.6880.698
Accounts Receivables -35.065-33.247-39.358-1.303-6.6210.088-4.269-0.899-0.566-0.0590.672-0.2910000
Inventory 0000000000000000
Accounts Payables 24.4889.11628.577-23.89710.14636.653-2.7115.48200000000
Other Working Capital 22.01345.56313.668106.4767.215-8.03719.7697.7988.64-1.1272.14800000
Other Non Cash Items 53.89274.91555.6210.243-0.55611.3979.220.4030.119-0.162-0.0320.349-24.442-17.896-0.122-0.784
Operating Cash Flow -755.654-502.733-481.168-290.274-334.775-204.56-150.105-94.563-57.799-23.623-14.865-20.633-27.139-18.094-13.792-15.576
Investing Activities:
Investments In Property Plant And Equipment -0.284-3.331-2.399-0.294-3.428-2.493-2.409-0.984-1.317-1.204-0.064-2.70700-0.013-3.935
Acquisitions Net 00000.0870.1270-1.92400000000
Purchases Of Investments 0000-0.087-493.984-240.898-197.506-1.479-0.115-4.465-3.8520000
Sales Maturities Of Investments 0232.6440182.82889.12510924615500000000
Other Investing Activites 0232.6440182.8280.087-0.127-0.214-0.114-1.479-0.115-0.064-2.707-1.739-0.38400
Investing Cash Flow -0.284229.313-2.399182.53485.784-387.4772.693-45.414-2.796-1.319-4.529-6.558-1.739-0.3840.487-3.935
Financing Activities:
Debt Repayment -7.545-728.373-4.857-4.674-4.424-0.044-0.048-0.043-0.039-0.519-0.036-0.0340000
Common Stock Issued 0396.19601,070.5813.186471.062545.401185.429248.16437.042045.0010000
Common Stock Repurchased 000000-0.401000000000
Dividends Paid 0000000000000000
Other Financing Activities -7.5451,449.858-4.857-0.001-7.646-20.755-30.098-7.547-22.038-1.5190.51942.26729.81318.0880-5.998
Financing Cash Flow -7.5451,117.681-4.8571,065.906-8.884450.307514.902177.882226.12635.0040.51945.00129.81318.0888-5.998
Other Information:
Effect Of Forex Changes On Cash -0.6360.5760.403-0.5010.1310.0930000000000
Net Change In Cash -764.119844.837-488.02957.665-257.744-141.637367.4937.905165.53110.062-18.87617.810.935-0.39-5.305-25.509
Cash At End Of Period 732.061,496.179651.3421,139.362181.697439.441581.078213.588175.68310.1520.0918.9661.1570.2220.6125.917